Combined immunosuppressants and less steroids in active graves’ orbitopathy?

Abstract

Steroid therapy in GO is first line treatment but has limitations, as it is potentially harmful at high doses and often refused by patients. A steroid sparing therapy is a reasonable option as long as it is rapidly effective and devoid of long term adverse reactions. Combined immunosuppressive therapy must be studied in randomized clinical trials designed to test efficacy and the potentially increased risk of side effects.

This article is protected by copyright. All rights reserved.

https://ift.tt/2SN3Jkg